Clot Management Devices Market Size, Growth, Trends, Report 2028

Report Description

Global clot management devices market is expected to register steady CAGR during the forecast period, 2024-2028. This can be ascribed to the increasing cardiovascular diseases along with rising aging population across the world. Additionally, advancement of technologies in clot management devices to improve the diagnosis and treatment of problems like stroke and growing preference for minimally invasive procedures by both patients and healthcare increased the demand for clot management device market for the forecast period. The sedentary lifestyles and unhealthy dietary habits and increasing instances of hip, knee and spinal injuries across the globe, are some of the major factors driving the global clot management device market during the forecast period. The research and clinical trial related to clot management device have significantly increased over the years.

Rising Demand for Stent Retrievers

Stent retrievers are second-generation mechanical thrombectomy products utilized for the treatment of thrombotic disorders. The increasing prevalence of cardiovascular disease because of increase in alcohol consumption, smoking, stress and unhealthy foods and growing aging population across the world, are propelling the clot management device market growth during the forecast period. One of the important factors that drive the market growth is the increasing availability of reimbursement of thrombectomy procedures, rising public and private investments for product development and commercialization and increasing patient emphasis with minimally invasive procedure. Ongoing drug developments by leading companies and expansion of the presence in emerging countries by the market players through the establishment of manufacturing facilities, research and development facilities and distribution networks are the important factors that significantly contribute to the growth of the clot management devices market during the forecast period.

Increasing Availability of Medical Reimbursements

With continued technical breakthroughs in the field of minimally invasive operations, thrombectomy systems are currently being used in hospitals and surgical centres in collaboration with diagnostic technologies for image-guided thrombectomy procedures. The frequency of thrombectomy procedures performed in hospitals and surgical centres is rising due to the increased use of stent and clot retrievers in treating acute ischemic stroke and the rising incidence of chronic vascular illnesses. Apart from this, main market players are focusing on research and development sector to create an advance technology in thrombectomy devices. Major players are collaborating with academic and research institutes to get the support on their ongoing clinical projects and rising public private funding to support research projects in the field of thrombectomy to develop novel thrombectomy technology, which is expected to drive the overall clot management device market growth during the forecast period.

Download Free Sample Report

Market Segmentation
Global Clot Management Devices market is segmented on the basis of product type, end user, and region. Based on product type, the market can be segmented into neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter directed thrombolysis devices, and others. Based on end user, the market can be segmented into hospitals & clinics, ambulatory care centers, and others. Regionally, Europe dominated the market among Asia Pacific, North America, Middle East & Africa and South America. In terms of country, the United States is dominating the global clot management devices market. This can be ascribed to the increasing cost-effective devices in the healthcare sector. According to the World Health Organization (WHO), the number of people suffering from deep vein thrombosis (DVT) and pulmonary embolism (PE) is much larger than people suffering from AIDS and cancer. During the year 2015, around 9,00,000 people were diagnosed with DVT & PE in the United States.

Market Players

Medtronic Plc., Concentric Medical, Inc., Boston Scientific Corporation, Edward LifeSciences Corporation, AngioDynamics, Inc., LeMaitre Vascular, Inc., Teleflex Incorporated, Johnson & Johnson, Strub Medical GmbH & Co. KG, Cook Group Incorporated are some of the leading players operating in the Global Clot Management Devices Market.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2022
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, Volume in Units, and CAGR for 2018-2022 and 2023-2028
Report coverage	Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends
Segments covered	By Product Type By End User By Region
Regional scope	North America, Europe, Asia Pacific, South America, Middle East & Africa
Country scope	United States, Mexico, Canada, France, Germany, United Kingdom, Italy, Spain, China, India, South Korea, Japan, Australia, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, UAE, Egypt, Turkey
Key companies profiled	Medtronic Plc., Concentric Medical, Inc., Boston Scientific Corporation, Edward LifeSciences Corporation, AngioDynamics, Inc., LeMaitre Vascular, Inc., Teleflex Incorporated, Johnson & Johnson, Strub Medical GmbH & Co. KG, Cook Group Incorporated
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Global Clot Management Devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Clot Management Devices Market, By Product Type:

Neurovascular Embolectomy Devices
Embolectomy Balloon Catheters
Percutaneous Thrombectomy Devices
Catheter Directed Thrombolysis Devices
Others

Clot Management Devices Market, By End User:

Hospitals & Clinics
Ambulatory Care Centers
Others

· Clot Management Devices Market, By Region:

North America

United States
Mexico
Canada

Europe

France
Germany
United Kingdom
Italy
Spain

Asia Pacific

China
India
South Korea
Japan
Australia

South America

Brazil
Argentina
Colombia

Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

§ Egypt

§ Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Clot Management Devices Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Clot Management Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clot Management Devices Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter Directed Thrombolysis Devices, Others)

5.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)

5.2.3. By Company (2022)

5.2.4. By Region

5.3. Market Map

5.3.1. By Product Type

5.3.2. By End User

5.3.3. By Region

6. North America Clot Management Devices Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product Type

6.2.2. By End User

6.2.3. By Country

6.3. North America: Country Analysis

6.3.1. United States Clot Management Devices Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product Type

6.3.1.2.2. By End User

6.3.2. Mexico Clot Management Devices Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product Type

6.3.2.2.2. By End User

6.3.3. Canada Clot Management Devices Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product Type

6.3.3.2.2. By End User

7. Europe Clot Management Devices Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product Type

7.2.2. By End User

7.2.3. By Country

7.3. Europe: Country Analysis

7.3.1. France Clot Management Devices Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product Type

7.3.1.2.2. By End User

7.3.2. Germany Clot Management Devices Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product Type

7.3.2.2.2. By End User

7.3.3. United Kingdom Clot Management Devices Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product Type

7.3.3.2.2. By End User

7.3.4. Italy Clot Management Devices Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product Type

7.3.4.2.2. By End User

7.3.5. Spain Clot Management Devices Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product Type

7.3.5.2.2. By End User

8. Asia-Pacific Clot Management Devices Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product Type

8.2.2. By End User

8.2.3. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Clot Management Devices Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product Type

8.3.1.2.2. By End User

8.3.2. India Clot Management Devices Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product Type

8.3.2.2.2. By End User

8.3.3. South Korea Clot Management Devices Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product Type

8.3.3.2.2. By End User

8.3.4. Japan Clot Management Devices Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product Type

8.3.4.2.2. By End User

8.3.5. Australia Clot Management Devices Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product Type

8.3.5.2.2. By End User

9. South America Clot Management Devices Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product Type

9.2.2. By End User

9.2.3. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Clot Management Devices Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product Type

9.3.1.2.2. By End User

9.3.2. Argentina Clot Management Devices Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product Type

9.3.2.2.2. By End User

9.3.3. Colombia Clot Management Devices Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product Type

9.3.3.2.2. By End User

10. Middle East and Africa Clot Management Devices Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product Type

10.2.2. By End User

10.2.3. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Clot Management Devices Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product Type

10.3.1.2.2. By End User

10.3.2. Saudi Arabia Clot Management Devices Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product Type

10.3.2.2.2. By End User

10.3.3. UAE Clot Management Devices Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product Type

10.3.3.2.2. By End User

10.3.4. Egypt Clot Management Devices Market Outlook

10.3.4.1. Market Size & Forecast

10.3.4.1.1. By Value

10.3.4.2. Market Share & Forecast

10.3.4.2.1. By Product Type

10.3.4.2.2. By End User

10.3.5. Turkey Clot Management Devices Market Outlook

10.3.5.1. Market Size & Forecast

10.3.5.1.1. By Value

10.3.5.2. Market Share & Forecast

10.3.5.2.1. By Product Type

10.3.5.2.2. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Competitive Landscape

13.1. Business Overview

13.2. Company Snapshot

13.3. Products & Services

13.4. Financials (As reported)

13.5. Recent Developments

13.6. SWOT Analysis

13.6.1. Medtronic Plc.

13.6.2. Concentric Medical, Inc.

13.6.3. Boston Scientific Corporation

13.6.4. Edward LifeSciences Corporation

13.6.5. AngioDynamics, Inc.

13.6.6. LeMaitre Vascular, Inc.

13.6.7. Teleflex Incorporated

13.6.8. Johnson & Johnson

13.6.9. Strub Medical GmbH & Co. KG

13.6.10. Cook Group Incorporated

14. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Clot Management Devices Market?

Increasing prevalence of cardiovascular diseases (CVDs), along with the rising geriatric population across the globe are the major drivers for the Global Clot Management Devices Market.

Who are the top players operating in the Clot Management Devices Market?

Medtronic Plc., Concentric Medical, Inc., Boston Scientific Corporation, Edward LifeSciences Corporation, AngioDynamics, Inc., LeMaitre Vascular, Inc., Teleflex Incorporated, Johnson & Johnson, Strub Medical GmbH & Co. KG, Cook Group Incorporated are the leading players operating in the Global Clot Management Devices Market.

Which product type is expected to dominate the Clot Management Devices Market during the forecast period?

Neurovascular Embolectomy device is expected to dominate in the market during the forecast period.

Which region is expected to have the largest share in the Global Clot Management Devices Market?

Asia-Pacific is expected to have the largest share in the Global Clot Management Devices Market during the forecast period.

Buy Now